## Core Concept
Interstitial lung disease (ILD) refers to a broad category of lung diseases characterized by inflammation and scarring (fibrosis) in the lung tissue. Drug-induced ILD is a well-recognized entity, with various medications capable of causing lung injury through different mechanisms.

## Why the Correct Answer is Right
The correct answer, , is not known to cause interstitial lung disease. This could be due to its pharmacological properties or metabolism that do not lead to lung toxicity. Specific drugs are known to induce ILD, often through mechanisms like direct toxicity, immune-mediated reactions, or modulation of inflammatory responses.

## Why Each Wrong Option is Incorrect
* **Option A:** is known to cause ILD. This drug can lead to lung injury, likely through direct toxic effects or immune modulation.
* **Option B:** can cause ILD. Its mechanism might involve the induction of an immune response or direct cytotoxic effects on lung cells.
* **Option C:** is associated with ILD. This association might be due to its ability to cause inflammation or fibrosis in the lung tissue.

## Clinical Pearl / High-Yield Fact
A high-yield fact to remember is that certain drugs are more commonly associated with ILD, such as **bleomycin** (an anticancer agent), **amiodarone** (an antiarrhythmic), and **methotrexate** (an immunosuppressant). When prescribing or administering these medications, monitoring for signs of lung toxicity is crucial.

## Correct Answer Line
**Correct Answer: .**